Showing results (941-950 of 5,009) with videos related to

Sort By:
Pageof 501
American Journal of Clinical Oncology|January 5, 2019
Survival Implications of De Novo Versus Recurrent Metastatic Non-Small Cell Lung CancerSara Moore, Bonnie Leung, Jonn Wu, et al.
American Journal of Clinical Oncology|January 3, 2019
Sequencing of Chemotherapy and Radiotherapy for Newly Diagnosed Anaplastic Oligodendroglioma and OligoastrocytomaJeffrey M Ryckman, Swati M Surkar, Waqar Haque, et al.
American Journal of Clinical Oncology|March 13, 2018
Literature Review of Spinal Cord GlioblastomaJoshua J Timmons, Kisa Zhang, Johnson Fong, et al.
American Journal of Clinical Oncology|January 1, 1988
Relationship of androgen receptors to the growth and regression of the prostateP S Rennie, N Bruchovsky, S L Goldenberg
American Journal of Clinical Oncology|January 1, 1988
Antiandrogens in combination with LH-RH agonists in prostate cancerJ P Raynaud
American Journal of Clinical Oncology|January 1, 1988
The assessment of subjective response in prostatic cancer clinical researchN K Aaronson
American Journal of Clinical Oncology|September 25, 2020
Adjuvant FOLFOX+Nab-Paclitaxel (FOLFOX-A) for Pancreatic Cancer: A Brown University Oncology Research Group Phase II Study (BrUOG295)Alexander G Raufi, Rimini Breakstone, Kara Leonard, et al.
American Journal of Clinical Oncology|December 1, 1988
Treatment of the blastic phase of chronic myelogenous leukemia with high-dose cytosine arabinosideT J Ernst, D S Rosenthal, J D Griffin, et al.
American Journal of Clinical Oncology|December 1, 1988
Continuous infusion homoharringtonine (NSC 141633) in refractory acute nonlymphocytic leukemia. An ECOG pilot studyJ A Stewart, P A Cassileth, J M Bennett, et al.
American Journal of Clinical Oncology|April 7, 2020
A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid TumorsPaul C McDonald, Stephen Chia, Philippe L Bedard, et al.
Pageof 501